ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
17.81
-0.21 (-1.17%)
Aug 14, 2025, 11:39 AM - Market open
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $722.53 million as of August 14, 2025. Its market cap has decreased by -0.50% in one year.
Market Cap
722.53M
Enterprise Value
474.37M
1-Year Change
-0.50%
Ranking
Category
Stock Price
$17.81
Market Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $722.53M, an increase of 25.61%. That is a compound annual growth rate of 15.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 731.05M | -18.56% |
| Dec 31, 2024 | 897.69M | 56.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |